NEW YORK (GenomeWeb News) – If the US wants to maintain its place as the global leader in scientific innovation then the longstanding tradition of partnership between federal and state governments, research universities, and technology-based businesses needs to be reinvigorated with more stable government funding, streamlined regulations, and incentivizing tax policies, members of a National Research Council panel told a House of Representatives subcommittee yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.